Browse result page of B3Pdb

The total number entries retrieved from this search are 507, scroll left/right for detailed information.

B3pdbID	PEPTIDE NAME	PEPTIDE SEQUENCE (1-letter)	PEPTIDE SEQUENCE (3-letter)	N-TERMINAL MODIFICATION	C-TERMINAL MODIFICATION	CHEMICAL MODIFICATION	PEPTIDE LENGTH	PEPTIDE CONFORMATION	PEPTIDE NATURE	SOURCE/ORIGIN OF PEPTIDE	SMILES	CELL LINE	In vitro CONCENTRATION	In vitro METHOD	In vitro RESULT	ANIMAL MODEL	In vivo CONCENTRATION	In vivo MODE OF DELIVERY	In vivo METHOD	In vivo RESULT	ACTION	TRANSPORT TYPE	SUBCELLULAR LOCALISATION	COMBINATION	PHYSICAL CONDITION	RESPONSE	RESULT	LABEL	PMID
b3pdb_0064	PPII(L3X;V13K)	VRXPPPVRLPPPKRLPPP	ValArgXaaProProProValArgLeuProProProLysArgLeuProProPro	Amide and CuAAC conjugated at N-terminus	NA	NA	18	Linear	NA	Chemically synthesized	N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N1[C@@]([H])(CCC1)C(=O)N1[C@@]([H])(CCC1)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CC(C)C)C(=O)N1[C@@]([H])(CCC1)C(=O)N1[C@@]([H])(CCC1)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CC(C)C)C(=O)N1[C@@]([H])(CCC1)C(=O)N1[C@@]([H])(CCC1)C(=O)N1[C@@]([H])(CCC1)C(=O)O	bEnd.3 cells	NA	Immunofluorescence microscopy	It shows the permeability towards the BBB.	NA	NA	NA	NA	NA	These novel peptide conjugates have the capacity to act as promising brain shuttles	Receptor-mediated transcytosis	NA	Combined	NA	NA	NA	NA	32055384
b3pdb_0065	Ang-2	CTFFYGGSRGKRNNFKTEE	CysThrPhePheTyrGlyGlySerArgGlyLysArgAsnAsnPheLysThrGluGlu	NA	NA	NA	19	Linear	NA	Chemically synthesized	N[C@@]([H])(CS)C(=O)N[C@@]([H])([C@]([H])(O)C)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)NCC(=O)NCC(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)NCC(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])([C@]([H])(O)C)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)O	NA	NA	NA	NA	C57BL6 mice	1 mg/mL	Intraperitoneal	Fluorescent microscopy	Localization of the nanoparticle within the brain cells, highlighting in particular the neuron accum	Brain-targeted PLGA nanoparticles were able to cross the BBB and accumulated in neuronal cells, thus	Transcytosis	NA	Conjugated to poly(lactic-co-glycolic acid) (PLGA)	NA	NA	NA	NA	31963430
b3pdb_0066	HAVN1	SHAVSS	SerHisAlaValSerSer	NA	NA	NA	6	Cyclic	NA	Chemically synthesized	N[C@@]([H])(CO)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CO)C(=O)O	NA	NA	NA	NA	C57BL6 mice	NA	Intracerebral ventricular	Mass Spectromtery	It is able to deliver an IRdye800CW-labeled IgG monoclonal antibody into the brain.	Synthesized novel cyclic peptides are able efectively modulate the BBB to enhance the delivery of mA	NA	NA	Combined with monoclonal antibody	NA	NA	NA	NA	31683745
b3pdb_0067	HAVN2	SHAVS	SerHisAlaValSer	NA	NA	NA	5	Cyclic	NA	Chemically synthesized	N[C@@]([H])(CO)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CO)C(=O)O	NA	NA	NA	NA	C57BL6 mice	NA	Intracerebral ventricular	Mass Spectromtery	It is able to deliver an IRdye800CW-labeled IgG monoclonal antibody into the brain.	Synthesized novel cyclic peptides are able efectively modulate the BBB to enhance the delivery of mA	NA	NA	Combined with monoclonal antibody	NA	NA	NA	NA	31683745
b3pdb_0068	Linear ADTHAV	TPPVSHAV	ThrProProValSerHisAlaVal	Acetylaed at N-terminal	Amide group is attached at C-terminal	NA	8	Linear	NA	Chemically synthesized	N[C@@]([H])([C@]([H])(O)C)C(=O)N1[C@@]([H])(CCC1)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C(C)C)C(=O)O	NA	NA	NA	NA	C57BL6 mice	NA	Intracerebral ventricular	Mass Spectromtery	It is able to deliver an IRdye800CW-labeled IgG monoclonal antibody into the brain.	Synthesized novel cyclic peptides are able efectively modulate the BBB to enhance the delivery of mA	NA	NA	Combined with monoclonal antibody	NA	NA	NA	NA	31683745
b3pdb_0069	Cyclic ADTHAV	TPPVSHAV	ThrProProValSerHisAlaVal	NA	NA	NA	8	Cyclic	NA	Chemically synthesized	N[C@@]([H])([C@]([H])(O)C)C(=O)N1[C@@]([H])(CCC1)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C(C)C)C(=O)O	NA	NA	NA	NA	C57BL6 mice	NA	Intracerebral ventricular	Mass Spectromtery	It is able to deliver an IRdye800CW-labeled IgG monoclonal antibody into the brain.	Synthesized novel cyclic peptides are able efectively modulate the BBB to enhance the delivery of mA	NA	NA	Combined with monoclonal antibody	NA	NA	NA	NA	31683745
b3pdb_0070	ADTC5	CDTPPVC	CysAspThrProProValCys	NA	Amide group is attached at C-terminal	NA	7	Cyclic	NA	Chemically synthesized	N[C@@]([H])(CS)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])([C@]([H])(O)C)C(=O)N1[C@@]([H])(CCC1)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CS)C(=O)O	NA	NA	NA	NA	C57BL6 mice	NA	Intracerebral ventricular	Mass Spectromtery	It is able to deliver an IRdye800CW-labeled IgG monoclonal antibody into the brain.	Synthesized novel cyclic peptides are able efectively modulate the BBB to enhance the delivery of mA	NA	NA	Combined with monoclonal antibody	NA	NA	NA	NA	31683745
b3pdb_0147	Goldnanoparticle con	THRPPMWSPVWP	ThrHisArgProProMetTrpSerProValTrpPro	NA	NA	Conjugated with CLPFFD goldnaNAparticle	12	Linear	Cationic	Chemically synthesized	NA	NA	NA	NA	NA	Adult Sprague-Dawley rats	1.86 mg/Kg	Intraperitoneal	Instrumental neutron activation analysis and Nissl staining	Conjugate was found to cross blodd brain barrier; does not effect mice survival; no toxicity as meas	NA	NA	NA	NA	Alzheimer	NA	NA	NA	22795856
b3pdb_0150	MMP-2200	Y-D-TGFLS(β-O-Glc)-CONH2	Tyr-D-Thr-Gly-Phe-Leu-Ser(Î²-O-Glc)-CONH2	NA	NA	Glycosylated serine residue	6	Linear	NA	Chemically synthesized	NA	NA	NA	NA	NA	Adult Sprague-Dawley rats	10mg/Kg	Intraperitoneal	Microdialysis analysis and LCMS analysis	Significant amount of peptide crosses blood brain barrier after 12 minute and remain stable up to 80	Shows potent analgesic behaviour	NA	NA	NA	Parkinson	Stability/half life	80 minute	NA	23127847
b3pdb_0151	MPEG-PCL-Tat	NA	NA	Addition of MPEG and ploygalactolactone	NA	Addition of MPEG and PCL	NA	Linear	NA	Chemically synthesized	NA	NA	NA	NA	NA	Adult Sprague-Dawley rats	100 microliter	Intravenous	Fluoroscent screening by FITC labbled peptide maass in brain tissue	0.5% fluoroscence observed in brain tissue	NA	NA	NA	NA	NA	NA	NA	NA	23992922
b3pdb_0152	MPEG-PCL-Tat	NA	NA	Addition of MPEG and ploygalactolactone	NA	Addition of MPEG and PCL	NA	Linear	NA	Chemically synthesized	NA	NA	NA	NA	NA	Adult Sprague-Dawley rats	10 microliter	Intranasal	Fluoroscent screening by FITC labbled peptide maass in brain tissue	2.5% fluoroscence observed in brain tissue	NA	NA	NA	NA	NA	NA	NA	NA	23992922
b3pdb_0153	Apomin	CNCKAPETALCARRCQQH	CysAsnCysLysAlaProGluThrAlaLeuCysAlaArgArgCysGlnGlnHis	NA	NA	NA	18	Linear	NA	Chemically synthesized	NA	Caco-2 cell line	200 microliter of peptide	BBB-RTU cell kit assay PAMPA method	The difference in peptide concentration between donor and acceptor cell was below 1%, indicate cells	NA	NA	NA	NA	NA	NA	NA	NA	NA	CNS	NA	NA	NA	24281722
b3pdb_0154	Apomin	CNCKAPETALCARRCQQH	CysAsnCysLysAlaProGluThrAlaLeuCysAlaArgArgCysGlnGlnHis	NA	NA	NA	18	Cyclic	NA	Chemically synthesized	NA	Caco-2 cell line	200 microliter of peptide	BBB-RTU cell kit assay PAMPA method	1.7+/- 0.1 apparent permeability	NA	NA	NA	NA	NA	NA	NA	NA	NA	CNS	NA	NA	NA	24281722
b3pdb_0155	Apoo	CNCKAPETALCARRCQQH	CysAsnCysLysAlaProGluThrAlaLeuCysAlaArgArgCysGlnGlnHis	NA	NA	NA	18	Cyclic	NA	Chemically synthesized	NA	Caco-2 cell line	200 microliter of peptide	BBB-RTU cell kit assay PAMPA method	1.6+/- 0.2 apparent permeability	NA	NA	NA	NA	NA	NA	NA	NA	NA	CNS	NA	NA	NA	24281722
b3pdb_0156	Apoo	CNCKAPETALCARRCQQH	CysAsnCysLysAlaProGluThrAlaLeuCysAlaArgArgCysGlnGlnHis	NA	NA	NA	18	Cyclic	NA	Chemically synthesized	NA	Caco-2 cell line	100 microliter of peptide	BBB-RTU cell kit assay PAMPA method	2.3+/- 0.7 apparent permeability	NA	NA	NA	NA	NA	NA	NA	NA	NA	CNS	NA	NA	NA	24281722
b3pdb_0157	Apomin	CNCKAPETALCARRCQQH	CysAsnCysLysAlaProGluThrAlaLeuCysAlaArgArgCysGlnGlnHis	NA	NA	NA	18	Cyclic	NA	Chemically synthesized	NA	Caco-2 cell line	200 microliter of peptide	BBB-RTU cell kit assay PAMPA method	1.8+/- 0.1 apparent permeability	NA	NA	NA	NA	NA	NA	NA	NA	NA	CNS	NA	NA	NA	24281722
b3pdb_0158	Apoo	CNCKAPETALCARRCQQH	CysAsnCysLysAlaProGluThrAlaLeuCysAlaArgArgCysGlnGlnHis	NA	NA	NA	18	Cyclic	NA	Chemically synthesized	NA	Caco-2 cell line	200 microliter of peptide	BBB-RTU cell kit assay PAMPA method	1.7+/- 0.2 apparent permeability	NA	NA	NA	NA	NA	NA	NA	NA	NA	CNS	NA	NA	NA	24281722
b3pdb_0159	Apoo	CNCKAPETALCARRCQQH	CysAsnCysLysAlaProGluThrAlaLeuCysAlaArgArgCysGlnGlnHis	NA	NA	NA	18	Cyclic	NA	Chemically synthesized	NA	Caco-2 cell line	100 microliter of peptide	BBB-RTU cell kit assay PAMPA method	2.5+/- 0.8 apparent permeability	NA	NA	NA	NA	NA	NA	NA	NA	NA	CNS	NA	NA	NA	24281722
b3pdb_0216	NA	RGD	ArgGlyAsp	NA	NA	NA	3	Linear	Cationic	Chemically synthesized	NA	BCEC cell line	0.3 microgram of peptide per ml	Competition assay	Nearly 5% diffuse into acceptor chamber after 2 hours	NA	NA	NA	NA	NA	NA	NA	NA	peptide combined with paclitaxel and Doxorubicin	Brain glioma therapy	NA	NA	NA	27143884
b3pdb_0217	NA	RGD	ArgGlyAsp	NA	NA	NA	3	Cyclic	Cationic	Chemically synthesized	NA	BCEC cell line	0.3 microgram of peptide per ml	Competition assay	Nearly 5% diffuse into acceptor chamber after 2 hours	NA	NA	NA	NA	NA	NA	NA	NA	peptide combined with paclitaxel and Doxorubicin	Brain glioma therapy	NA	NA	NA	27143884
b3pdb_0218	NA	RGD	ArgGlyAsp	NA	NA	NA	3	Linear	Cationic	Chemically synthesized	NA	BCEC cell line	0.3 microgram of peptide per ml	Competition assay	Nearly7% diffuse into acceptor chamber after 4 hours	NA	NA	NA	NA	NA	NA	NA	NA	peptide combined with paclitaxel and Doxorubicin	Brain glioma therapy	NA	NA	NA	27143884
b3pdb_0219	NA	RGD	ArgGlyAsp	NA	NA	NA	3	Cyclic	Cationic	Chemically synthesized	NA	BCEC cell line	0.3 microgram of peptide per ml	Competition assay	Nearly 5% diffuse into acceptor chamber after 4 hours	NA	NA	NA	NA	NA	NA	NA	NA	peptide combined with paclitaxel and Doxorubicin	Brain glioma therapy	NA	NA	NA	27143884
b3pdb_0220	NA	RGD	ArgGlyAsp	NA	NA	NA	3	Linear	Cationic	Chemically synthesized	NA	BCEC cell line	0.3 microgram of peptide per ml	Competition assay	Nearly 15% diffuse into acceptor chamber after 8 hours	NA	NA	NA	NA	NA	NA	NA	NA	peptide combined with paclitaxel and Doxorubicin	Brain glioma therapy	NA	NA	NA	27143884
b3pdb_0221	NA	RGD	ArgGlyAsp	NA	NA	NA	3	Cyclic	Cationic	Chemically synthesized	NA	BCEC cell line	0.3 microgram of peptide per ml	Competition assay	Nearly 7% diffuse into acceptor chamber after 8 hours	NA	NA	NA	NA	NA	NA	NA	NA	peptide combined with paclitaxel and Doxorubicin	Brain glioma therapy	NA	NA	NA	27143884
b3pdb_0222	NA	RGD	ArgGlyAsp	NA	NA	NA	3	Linear	Cationic	Chemically synthesized	NA	BCEC cell line	0.3 microgram of peptide per ml	Competition assay	Nearly 20% diffuse into acceptor chamber after 24 hours	NA	NA	NA	NA	NA	NA	NA	NA	peptide combined with paclitaxel and Doxorubicin	Brain glioma therapy	NA	NA	NA	27143884
b3pdb_0223	NA	RGD	ArgGlyAsp	NA	NA	NA	3	Cyclic	Cationic	Chemically synthesized	NA	BCEC cell line	0.3 microgram of peptide per ml	Competition assay	Nearly 15% diffuse into acceptor chamber after 24 hours	NA	NA	NA	NA	NA	NA	NA	NA	peptide combined with paclitaxel and Doxorubicin	Brain glioma therapy	NA	NA	NA	27143884
b3pdb_0224	NA	RGD	ArgGlyAsp	NA	NA	NA	3	Linear	Cationic	Chemically synthesized	NA	BCEC cell line	0.3 microgram of peptide per ml	Competition assay	Nearly 2% diffuse into acceptor chamber after 2 hours	NA	NA	NA	NA	NA	NA	NA	NA	peptide combined with paclitaxel and Doxorubicin	Brain glioma therapy	NA	NA	NA	27143884
b3pdb_0225	NA	RGD	ArgGlyAsp	NA	NA	NA	3	Cyclic	Cationic	Chemically synthesized	NA	BCEC cell line	0.3 microgram of peptide per ml	Competition assay	Nearly 2% diffuse into acceptor chamber after 2 hours	NA	NA	NA	NA	NA	NA	NA	NA	peptide combined with paclitaxel and Doxorubicin	Brain glioma therapy	NA	NA	NA	27143884
b3pdb_0226	NA	RGD	ArgGlyAsp	NA	NA	NA	3	Linear	Cationic	Chemically synthesized	NA	BCEC cell line	0.3 microgram of peptide per ml	Competition assay	Nearly5% diffuse into acceptor chamber after 4 hours	NA	NA	NA	NA	NA	NA	NA	NA	peptide combined with paclitaxel and Doxorubicin	Brain glioma therapy	NA	NA	NA	27143884
b3pdb_0227	NA	RGD	ArgGlyAsp	NA	NA	NA	3	Cyclic	Cationic	Chemically synthesized	NA	BCEC cell line	0.3 microgram of peptide per ml	Competition assay	Nearly 3% diffuse into acceptor chamber after 4 hours	NA	NA	NA	NA	NA	NA	NA	NA	peptide combined with paclitaxel and Doxorubicin	Brain glioma therapy	NA	NA	NA	27143884
b3pdb_0228	NA	RGD	ArgGlyAsp	NA	NA	NA	3	Linear	Cationic	Chemically synthesized	NA	BCEC cell line	0.3 microgram of peptide per ml	Competition assay	Nearly 12% diffuse into acceptor chamber after 8 hours	NA	NA	NA	NA	NA	NA	NA	NA	peptide combined with paclitaxel and Doxorubicin	Brain glioma therapy	NA	NA	NA	27143884
b3pdb_0229	NA	RGD	ArgGlyAsp	NA	NA	NA	3	Cyclic	Cationic	Chemically synthesized	NA	BCEC cell line	0.3 microgram of peptide per ml	Competition assay	Nearly 5% diffuse into acceptor chamber after 8 hours	NA	NA	NA	NA	NA	NA	NA	NA	peptide combined with paclitaxel and Doxorubicin	Brain glioma therapy	NA	NA	NA	27143884
b3pdb_0230	NA	RGD	ArgGlyAsp	NA	NA	NA	3	Linear	Cationic	Chemically synthesized	NA	BCEC cell line	0.3 microgram of peptide per ml	Competition assay	Nearly 25% diffuse into acceptor chamber after 24 hours	NA	NA	NA	NA	NA	NA	NA	NA	peptide combined with paclitaxel and Doxorubicin	Brain glioma therapy	NA	NA	NA	27143884
b3pdb_0231	NA	RGD	ArgGlyAsp	NA	NA	NA	3	Cyclic	Cationic	Chemically synthesized	NA	BCEC cell line	0.3 microgram of peptide per ml	Competition assay	Nearly 15% diffuse into acceptor chamber after 24 hours	NA	NA	NA	NA	NA	NA	NA	NA	peptide combined with paclitaxel and Doxorubicin	Brain glioma therapy	NA	NA	NA	27143884
b3pdb_0232	NA	RGD	ArgGlyAsp	NA	NA	NA	3	Linear	Cationic	Chemically synthesized	NA	NA	NA	NA	NA	BALB/c mice xenograft for U87MG glioma cells	5mg/Kg	Intravenous	Fluoroscent measurement	Significant amount of drugsa delivered in brain tissue	Peptide can deliver drugs into brain tissue	NA	NA	Doxorubicin+paclitaxel in 5mg/Kg combination	Brain glioma therapy	NA	NA	NA	27143884
b3pdb_0242	Endmorphin analog -1	YPW-(R,R)-AMBP-NH2	H-Tyr-Pro-Trp-(R,R)-AMBP-NH2	NA	NA	Addition of alpha-methyl-beta-phenylalanine	NA	Linear	Cationic	Chemically synthesized	NA	Opioid receptor	50 microlitre	HPLC	21.2+/- 3.71 ki value	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	28567467
b3pdb_0243	Endmorphin analog -2	H-TYW-(S,S)-AMBP-NH2	H-Tyr-Pro-Trp-(S,S)-AMBP-NH2	NA	NA	Addition of alpha-methyl-beta-phenylalanine	NA	Linear	Cationic	Chemically synthesized	NA	Opioid receptor	50 microlitre	HPLC	7.7+/- 1.94 ki value	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
b3pdb_0244	Endmorphin analog -3	H-YPW-(R,R)-AMBF-NH2	H-Tyr-Pro-Trp-(R,R)-AMBF-NH2	NA	NA	Addition of alpha-methyl-beta-furylalanine	NA	Linear	Cationic	Chemically synthesized	NA	Opioid receptor	50 microlitre	HPLC	9.3+/- 2.58 ki value	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
b3pdb_0245	Endmorphin analog -4	H-YPW-(S,S)-AMBF-NH2	H-Tyr-Pro-Trp-(S,S)-AMBF-NH2	NA	NA	Addition of alpha-methyl-beta-furylalanine	NA	Linear	Cationic	Chemically synthesized	NA	Opioid receptor	50 microlitre	HPLC	6.3+/- 0.31 ki value	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
b3pdb_0246	Endmorphin analog -5	H-Dmt-PW-(R,R)-AMBP-NH2	H-Dmt-Pro-Trp-(R,R)-AMBP-NH2	NA	NA	Addition of alpha-methyl-beta-phenylalanine	NA	Linear	Cationic	Chemically synthesized	NA	Opioid receptor	50 microlitre	HPLC	0.75+/- 0.03 ki value	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
b3pdb_0247	Endmorphin analog -6	H-Dmt-PW-(S,S)-AMBP-NH2	H-Dmt-Pro-Trp-(S,S)-AMBP-NH2	NA	NA	Addition of alpha-methyl-beta-phenylalanine	NA	Linear	Cationic	Chemically synthesized	NA	Opioid receptor	50 microlitre	HPLC	0.31+/- 0.02 ki value	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
b3pdb_0248	Endmorphin analog -7	H-Dmt-PW-(R,R)-AMBF-NH2	H-Dmt-Pro-Trp-(R,R)-AMBF-NH2	NA	NA	Addition of alpha-methyl-beta-furylalanine	NA	Linear	Cationic	Chemically synthesized	NA	Opioid receptor	50 microlitre	HPLC	0.47+/- 0.02 ki value	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
b3pdb_0249	Endmorphin analog -8	H-Dmt-PW-(S,S)-AMBF-NH2	H-Dmt-Pro-Trp-(S,S)-AMBF-NH2	NA	NA	Addition of alpha-methyl-beta-furylalanine	NA	Linear	Cationic	Chemically synthesized	NA	Opioid receptor	50 microlitre	HPLC	0.12+/- 0.008 ki value	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
b3pdb_0250	Endmorphin analog -1	H-TYW-(R,R)-AMBP-NH2	H-Tyr-Pro-Trp-(R,R)-AMBP-NH2	NA	NA	Addition of alpha-methyl-beta-phenylalanine	NA	Linear	Cationic	Chemically synthesized	NA	Delta opioid receptor	50 microlitre	HPLC	6080+/- 640 ki value	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
b3pdb_0251	Endmorphin analog -2	H-TYW-(S,S)-AMBP-NH2	H-Tyr-Pro-Trp-(S,S)-AMBP-NH2	NA	NA	Addition of alpha-methyl-beta-phenylalanine	NA	Linear	Cationic	Chemically synthesized	NA	Delta opioid receptor	50 microlitre	HPLC	>10000 ki value	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
b3pdb_0252	Endmorphin analog -3	H-YPW-(R,R)-AMBF-NH2	H-Tyr-Pro-Trp-(R,R)-AMBF-NH2	NA	NA	Addition of alpha-methyl-beta-furylalanine	NA	Linear	Cationic	Chemically synthesized	NA	Delta opioid receptor	50 microlitre	HPLC	>10000 ki value	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
b3pdb_0253	Endmorphin analog -4	H-YPW-(S,S)-AMBF-NH2	H-Tyr-Pro-Trp-(S,S)-AMBF-NH2	NA	NA	Addition of alpha-methyl-beta-furylalanine	NA	Linear	Cationic	Chemically synthesized	NA	Delta opioid receptor	50 microlitre	HPLC	>10000 ki value	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
b3pdb_0254	Endmorphin analog -5	H-Dmt-PW-(R,R)-AMBP-NH2	H-Dmt-Pro-Trp-(R,R)-AMBP-NH2	NA	NA	Addition of alpha-methyl-beta-phenylalanine	NA	Linear	Cationic	Chemically synthesized	NA	Delta opioid receptor	50 microlitre	HPLC	>10000 ki value	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
b3pdb_0255	Endmorphin analog -6	H-Dmt-PW-(S,S)-AMBP-NH2	H-Dmt-Pro-Trp-(S,S)-AMBP-NH2	NA	NA	Addition of alpha-methyl-beta-phenylalanine	NA	Linear	Cationic	Chemically synthesized	NA	Delta opioid receptor	50 microlitre	HPLC	551+/- 38 ki value	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
b3pdb_0256	Endmorphin analog -7	H-Dmt-PW-(R,R)-AMBF-NH2	H-Dmt-Pro-Trp-(R,R)-AMBF-NH2	NA	NA	Addition of alpha-methyl-beta-furylalanine	NA	Linear	Cationic	Chemically synthesized	NA	Delta opioid receptor	50 microlitre	HPLC	273+/- 12 ki value	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

previous 123 4 5 6 7 8 9 10 11 next